30 Day Trial

BARE BONES content is posted to these pages in real time.

Monthly compilations are available in PDF form.

Product / Company Performance

Globus Medical Reports 4Q17, 2017 Sales Growth -

Globus Medical (GMED) announced preliminary 4Q17 sales of US $175.5MM, +15.8% vs. 4Q16, and 2017 sales of $635.4MM, +12.7% vs. 2016. Full-year revenue exceeds previously-stated guidance of $625.0MM. 

While full detail will be available in the final results to be published in late February, leadership noted that 4Q growth was 100% organic, as the anniversary of its acquisition of Alphatec's ex-U.S. business passed in September 2017. Growth was supported by U.S. spine revenue, sales in Japan and strong robotic sales.

GMED will use cash made available following U.S. tax legislation changes in part to increase spending on its Emerging Technologies, which include trauma and robotics, by $14.0MM in 2018.

For 2018, GMED established full-year revenue guidance of $690.0MM.

Source: Globus Medical, Inc.

This article is a Member-only item of content. Members, please log in to read the complete post.
If you are not yet a Member, click here to learn more about purchasing ORTHOWORLD Membership.